Skip to main content
Erschienen in: Reactions Weekly 1/2011

01.11.2011 | Case report

Parathyroid hormone withdrawal

Skeletal disorders: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literatur
1.
Zurück zum Zitat Gafni R, Christie CM, Kelly MH, Brillante BA, Reynolds J, Zhou H, Dempster DW, Collins M.Anabolic Skeletal Effects after Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (PTH) Replacement Therapy in Hypoparathyoidism (HPT). 33rd Annual Meeting of the American Society for Bone and Mineral Research: abstr. SU0123, 16 Sep 2011. Available from: URL: http://www.asbmr.org - USA Gafni R, Christie CM, Kelly MH, Brillante BA, Reynolds J, Zhou H, Dempster DW, Collins M.Anabolic Skeletal Effects after Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (PTH) Replacement Therapy in Hypoparathyoidism (HPT). 33rd Annual Meeting of the American Society for Bone and Mineral Research: abstr. SU0123, 16 Sep 2011. Available from: URL: http://​www.​asbmr.​org - USA
Metadaten
Titel
Parathyroid hormone withdrawal
Skeletal disorders: 2 case reports
Publikationsdatum
01.11.2011
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2011
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201113760-00076

Weitere Artikel der Ausgabe 1/2011

Reactions Weekly 1/2011 Zur Ausgabe

Case report

Ustekinumab

Case report

Tacrolimus

Case report

Etanercept

Case report

Isoniazid